Crystal (Howell) Hodge, PharmD, BCPS

Associate Professor of Pharmacotherapy

Education & Experience:

Having received my PharmD from the University of Texas at Austin. I completed a PGY-1 Pharmacy Practice Residency at Emory University Hospital followed with a PGY-2 Infectious Diseases Residency at Emory University Hospital Midtown and Emory University Hospital.

Teaching Areas & Interests:

“A mediocre teacher tells.  A good teacher explains.  The superior teacher demonstrates.  The great teacher inspires.” — William Arthur Ward

I mostly teach in infectious diseases (ID) courses or ID topics within other courses. I absolutely LOVE to share my passion for ID with others. Inspiring others to fight in the good fight against ID makes my heart swell with joy. Even if you don’t want to be an ID pharmacist, my goal is to help to make students feel comfortable and confident in treating patients that have infectious diseases. No matter how much students may want to avoid ID, it is ubiquitous, indiscriminate, and unescapable so they need to know how to treat the most common infections. I also take students on APPE rotations for ID, academia, and research. I love watching students grow and develop a passion for the field and the profession as a whole.

Five skill sets I strive to inspire in my students:

·   Desire to Learn

·   Lifelong Learning

·   Critical Thinking

·   Self-Reflection

·   Soft Skills

Clinical Interests:

·   Resistance mechanisms and multi-drug resistant gram negative infections

·   Fungal infections

·   Infections in immunocompromised hosts

·   Public Health

Scholarly Interests:

·   Interprofessional education

·   Community service learning

·   Scholarship of teaching and learning with an emphasis on infectious disease courses as well as APPEs

Professional Activities & Awards:

I am a Board Certified Pharmacotherapy Specialist with a teaching certificate from Mercer University.  I am actively involved in numerous organizations including the American Association of Colleges of Pharmacy (AACP), American College of Clinical Pharmacy (ACCP), American Society of Health-System Pharmacists (ASHP), American Society for Microbiology (ASM), Infectious Diseases Society of America (IDSA), Kappa Epsilon Professional Pharmacy Fraternity (KE), Phi Lambda Sigma Pharmacy Leadership Society (PLS), and the Society of Infectious Diseases Pharmacists (SIDP).

Professional Life Goal:  

I strive to effect change on three levels including patients, providers and the public.

Publications:

http://·         Six Steps to Learning Infectious Diseases in Pharmacotherapy (Including Bugs and Drugs) https://www.idstewardship.com/six-steps-learning-infectious-diseases-pharmacotherapy-including-bugs-drugs/

http://·         Up to Your Nostrils in Requests for Nasopharyngeal Tests? https://www.idstewardship.com/nostrils-requests-nasopharyngeal-tests-information-resources-appropriate-nasopharyngeal-sampling/

http://·         Know your medicine: A novel student-led community service learning program. DOI: 10.1016/j.cptl.2017.01.006

http://·         Retrospective cohort study evaluating the incidence of diabetic foot infections among hospitalized adults with diabetes in the United States from 1996-2010. DOI: 10.1016/j.ajic.2015.09.012

http://·         Epidemiology of Methicillin-Resistant Staphylococcus aureus Diabetic Foot Infections in a Large Academic Hospital: Implications for Antimicrobial Stewardship. DOI: 10.1371/journal.pone.0161658

http://·         Effect of positive perioperative donor and recipient respiratory bacterial cultures on early post-transplant outcomes in lung transplant recipients. DOI: 10.1111/tid.12760

http://·         Remote Antimicrobial Stewardship: A Solution for Meeting The Joint Commission Stewardship Standard? DOI: 10.1177/0018578718769240

http://·         Ramanathan MR, Howell CK, Sanders JM. Drugs in Tuberculosis and Leprosy. In: Side Effects of Drugs Annual, Vol. 40, Amsterdam: Elsevier, 2018;363-376. DOI:10.1016/bs.seda.2018.06.014

http://·         Ramanathan MR, Howell CK, Sanders JM. Drugs in Tuberculosis and Leprosy. In: Side Effects of Drugs Annual, Vol. 41, Amsterdam: Elsevier, 2019;321-338. DOI: 10.1016/bs.seda.2019.08.010

http://·         The Alteration of the Gut Microbiome by Immunosuppressive Agents Used in Solid Organ Transplantation. DOI: 10.1111/tid.13397